Member Info for KilkennyTed

The chairman will veto that as he bought 7k shares just 2 weeks ago. Stating we're not throwing more good money after bad.

13-Nov-20 12-Nov-20 Buy Jean-Pierre Crinelli 9.70 EUR 1,541 30,773
12-Nov-20 11-Nov-20 Buy Graham Mullis 817.00 GBX 60,875 122,506
11-Nov-20 10-Nov-20 Buy Edwin Snape 715.00 GBX 1,080 17,919

Basically nothing to see here.

https://novacyt.com/wp-content/uploads/2022/07/Novacyt-Results-of-AGM.pdf

Screenshot your shareholding. Upload to link. Cast votes.
Easy

https://novacyt.eventcaster.co.uk/access/login

https://www.heraldscotland.com/news/20286280.nhs-close-ceasing-function-amid-covid-waves/?ref=twtrec

"Why do investors keep treating the claim like it will wipe the bank balance? It's pretty clear."
It's intentional.

The company have stated that they are looking at market needs in relation to developing products. I think they are definitely targeting WHO when you look at what areas have been mentioned in Yearly report, presentation and recent rns update.
WHO file attached targets the same areas.
https://cdn.who.int/media/docs/default-source/hq-hiv-hepatitis-and-stis-library/full-final-who-ghss-hiv-vh-sti_1-june2022.pdf?sfvrsn=7c074b36_13

Want's governments to reverse the reduction in surveillance, testing & sequencing.
https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--12-july-2022

The Emergency Committee agreed that the #COVID19 pandemic remains a Public Health Emergency of International Concern. @DrTedros accepted the advice of the Committee and issued Temporary Recommendations, critical actions for countries to take.
https://www.who.int/news/item/12-07-2022-statement-on-the-twelfth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic

https://news.sky.com/story/covid-19-restrictions-could-be-reintroduced-if-rise-in-cases-hits-nhs-backlog-minister-warns-12650185

https://www.bioindustry.org/static/517ea7e6-e6b5-425d-b8f62c7aba988a1e/DIT-Genomics-Spotlight-Leading-Innovations-2022.pdf

One government department is in dispute with Novacyt over its products/services.
While another (the Department of International Trade) is promoting the same company as an innovator.

It's a VersaLab. Dam good idea .
https://twitter.com/Larry64450205/status/1542824807842078721?s=20&t=RaZlu2f-fmR8QHSX5kkaZw

Can you see what it is yet?

https://www.linkedin.com/feed/update/urn:li:activity:6948267552393330688?utm_source=linkedin_share&utm_medium=ios_app

"Powered by the innovations of the @NovacytGroup"
https://twitter.com/KilkennyTed/status/1542820744182235136?s=20&t=IoqSpjXeDkWjERUqidjnOQ

It's only been 2 weeks since Novacyt issued their counterclaim so don't expect any news on DHSC in the near future. However some larger investors may be positioning themselves in readiness. At these levels there's not much to lose.

World bank setting up a Pandemic preparedness and supply fund. They estimate it'll require $10.5billiin per year of external funding. Diagnostics will be part of this.

https://thedocs.worldbank.org/en/doc/018ab1c6b6d8305933661168af757737-0290032022/original/PPR-FIF-WB-White-Paper.pdf

https://coronavirus.data.gov.uk/
Hospital admissions on an upward curve.